Navigation Links
Liverpool receives $1.5M to tackle disease in Africa
Date:1/13/2011

A University of Liverpool-led consortium has received $1.5million from the Bill & Melinda Gates Foundation to study a bacterium that causes serious disease and epidemics in sub-Saharan Africa.

Streptococcus pneumoniae serotype1 is one of the most prevalent strains in sub-Sahara Africa. The funding will enable scientists to analyse the bacterium to determine why it is associated with invasive pneumococcal disease, why it spreads so quickly and why it has significant epidemic potential in some areas of Africa.

Invasive pneumococcal disease causes life-threatening pneumonia, meningitis and sepsis and is a major cause of death and serious illness in Africa. There are more than 90 different serotypes of Streptococcus pneumoniae - the bacterium that causes pneumococcal disease - but only a small number are associated with invasive pneumococcal disease.

Researchers based in Malawi, Nigeria, South Africa and The Gambia will analyse 300 wide-ranging and geographically relevant strains of Streptococcus pneumoniae serotype 1 to provide a detailed study of its genetic traits. The data will contribute to the current pneumococcal vaccine development programme led by PATH in the USA. In the longer term, the information will feed into the development of a protein-based vaccine that will enhance or replace current Pneumococcal Conjugate Vaccines (PCVs).

Vaccination provides the best form of protection against invasive pneumococcal disease. However, the vaccination programme that is being rolled out across Africa may not provide adequate protection against serotype 1. There are a number of PCVs currently available but none have shown a strong protective effect against serotype 1 and it is not known yet how the proposed PCVs which are due to be introduced to the programme will fare.

The project will also involve African researchers being trained to undertake the genomic-based research to enable local African researchers to process and analyse relevant data.

Dr Dean Everett, who is based in Malawi working as part of the Malawi-Liverpool-Wellcome Trust Clinical Research Programme, said: "Streptococcus pneumoniae serotype 1 is one of the biggest causes of pneumococcal disease in sub-Sahara Africa and accounts for a quarter of infections in Malawi."

"Understanding the genetic traits that underpin serotype 1 and contribute towards its epidemic potential will help us to refine vaccine target discovery and guide the vaccine development process in order to provide better protection to those in sub-Saharan Africa where this serotype is most prevalent. This is an important first step in the process and importantly it will be driven by researchers in Africa."

Partners organisation involved in the consortium include: the University of Liverpool; the Malawi College of Medicine; Centre de Recherche Medicale et Sanitaire, Niger; National Health Laboratory Service, South Africa; Medical Research Council, The Gambia; the Wellcome Trust; the Liverpool School of Tropical Medicine; the London School of Tropical Medicine and Emory University in the USA.


'/>"/>

Contact: Sarah Stamper
sarah.stamper@liv.ac.uk
01-517-943-044
University of Liverpool
Source:Eurekalert

Related medicine news :

1. Case Western Reserve receives $10M to study retinal disease, develop new treatments
2. University of Houston receives $5 million grant from Houston Endowment
3. BMC radiologist receives 2010 Marie Sklodowska-Curie Award from AAWR
4. Dartmouth receives $2 million grant for childrens health research center
5. Harvard expert on inflammations role in obesity receives Columbias 2010 Naomi Berrie Award
6. Earl Smith receives Prentice Medal from American Academy of Optometry
7. Fred Hutchinson Cancer Research Center scientist receives Presidential Early Career Award
8. Miriam receives $1.5 million from NIH to seek, test and treat inmates with HIV
9. National Jewish Health receives patent for diagnostic method of autoimmune chronic urticaria
10. Breast center receives RI Pink Heals donation
11. UC San Diego receives 2 major biomedical informatics grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... Reltok Nasal Products proudly announces that Boston Medical Products, ... nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product ... a newly patented safety device secured by nasal surgeons onto the floor of the ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... media enterprise focused entirely on patients with cancer, today announced that Lynne Malestic, ... as the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... and hospice software, outsourced billing and coding services, and Deyta Analytics, recently announced ... hospices providing the highest level of quality as measured from the caregiver’s point ...
(Date:4/29/2016)... ... April 29, 2016 , ... Pro3rd Grunge is a ... Film Studios’ lower thirds to introduce people, characters, and locations without having to set ... lines, accents, textures and many more design components. Simply select a preset and drag ...
(Date:4/28/2016)... ... 2016 , ... Monthly subscription boxes are all the rage, and "My Subscription ... the ZEN BOX , the aromatherapy subscription box. , ZEN BOX delivers three new ... frankincense) and one Zen Blend (like immune boost, sublime sleep or de-stress blends) ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 Dr. Vivek Ahuja , ... Ste phen Schmidt ... provider of cloud-based software solutions for life sciences, today announced key ... a wealth of insight to a growing business.  This will bolster ... George Phillips joined ArisGlobal in the position of Vice ...
(Date:4/28/2016)... , April 28, 2016 ... H1 2016" is a report that provides an ... strengthen R&D pipelines by identifying new targets and ... Company Profiles discussed in this H1 2016 ... Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx ...
(Date:4/27/2016)... TURIN, Italy , April 27, 2016 ... MR-guided linear accelerator (MR-linac) platform will be the focal ... annual meeting of the European Society for Radiotherapy & ... Elekta,s MR-linac integrates a state-of-the-art radiotherapy system and ... a physician to clearly see the patient,s anatomy in ...
Breaking Medicine Technology: